CClinicalTrials.gg
WithdrawnNCT04555122Updated May 3, 2023

COVID-19 Ad Intervention

An interventional study of Social Distancing Advertisements in Social Distance, sponsored by University of California, Irvine. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-03.

Sponsored by University of California, Irvine · Not applicable, Interventional, and Other

Why this study was withdrawn
Per Sponsor Request; nonACT
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will provide advertisements to (de-identified) participants and track (de-identified) movement patterns to learn whether the ads increase adherence to stay-at-home orders.

02

Conditions studied

  • Social Distance
03

In context

Lead sponsor

University of California, Irvine is the lead sponsor of 466 studies on the registry; 96 are open to participants now.

Of its 41 completed or terminated interventional studies of FDA-regulated products, 30 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18 years of age or older (as identified by company running advertisements); recent visit to a non-essential location; agreed to terms and conditions of websites allowing advertisements

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Advertisements will be sent to participants to attempt to increase adherence to stay-at-home orders and social distancing. There are 3 types of advertisements. This will occur for 7 days.

    Behavioral: Social Distancing Advertisements

  • No intervention
    Control Group

    Control Group will be people who will not receive any advertisements.

Interventions

  • BehavioralSocial Distancing Advertisements

    Participants will receive 3 types of advertisements to increase social distancing/staying at home.

06

What researchers measure

Primary outcomes

  1. Mobility

    Amount of time that participants are outside of their primary location/home

    Time frame: 7 days

07

Study locations

1 site
  • UC Irvine
    Irvine, California 92617, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04555122
Lead sponsor
University of California, Irvine
Collaborators
City University of Hong Kong, University of California, Los Angeles
Responsible party
Sean D Young (Associate Professor of Emergency Medicine and Informatics, University of California, Irvine) — Principal investigator
First posted
Sep 18, 2020
Start date
Oct 1, 2021 (estimated)
Primary completion
May 28, 2022 (estimated)
Completion
Jul 28, 2022 (estimated)
Last update
May 3, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion